Hat mitgewirkt an:
-
Identifikation von immunogenen Antigenen bei der akuten myeloischen Leukämie zur Entwicklung einer Tumorvakzine
-
Blockade of CD95/CD95L death signaling enhances CAR T cell persistence and antitumor efficacy
-
Optimizations of anti-tumor efficacy during CD19-specific chimeric antigen receptor (CAR) T/NK-cell manufacturing
-
Enhancement of cytotoxicity, expansion and persistence of CD19.CAR-T cells via pre-sensitization of B cell malignancies by inhibitors of Bcl-2 family proteins